Search

A woman contacted our Office after learning her OHIP coverage had been suspended while she was studying outside of Ontario, despite the fact that she had emailed her renewal documents to OHIP several times.

Investigation into whether the Ministry of Health and Long-Term Care has failed to properly administer newborn screening in Ontario.

The Ministry of Health and Long-Term care restored funding for testicular prosthesis surgery for boys under 18.

The Ministry of Health overhauled its out-of-country care program and paid $75,000 to a chemotherapy patient who was wrongly denied coverage.

Coverage was granted to a 94-year-old man who moved back to Ontario from the U.S. and broke his hip 38 days before his Ontario health insurance eligibility was to take effect.

The Ministry of Health and Long-Term Care agreed to fund the home use of oxygen saturation monitors for children with life-threatening respiratory conditions, and to review the entire Assistive Devices Program.

Investigation into the Ministry of Health and Long-Term Care’s administration of the Positron Emission Tomography (PET) program.

Investigation into the Ministry of Health and Long-Term Care’s decision-making concerning the funding of Avastin for colorectal cancer patients.

The Ministry of Health and Long-Term Care agreed to fund dental implants for a 55-year-old cancer patient who required extensive reconstructive facial surgery.

The Ministry of Health and Long-Term Care incorporated the Ombudsman’s suggestions in its ongoing upgrade of its monitoring of long-term care facilities after he identified serious systemic problems.

The owner of a home for adults with mental health issues contacted the Ombudsman, frustrated that he couldn’t get ODSP or Developmental Services Ontario (DSO) to provide funding to take one of his residents to her cancer treatments.

A woman whose teeth had been damaged as a result of physical abuse by her partner years earlier contacted the Ombudsman for help in obtaining funds to have them fixed.

The aunt and uncle of a 16-year-old boy with Down Syndrome needed help finding the boy a place to live after his mother died of cancer. They were concerned that they would not be able to care for him because they lived 270 kilometres away, both worked odd hours, and, due to their age, wouldn’t be able to look after him on a long-term basis.

A mother complained to the Ombudsman after she was forced to pay $7,000 for a spot for her adult daughter in a residential treatment program for women with substance abuse issues.

A farmer was concerned about the high electricity bills he received for the first six months of 2014, even though his corn dryer – the machine on his farm using the highest amount of electricity – wasn’t in use. His bills were close to $9,000, including $843 in delivery charges on $112 worth of electricity.

A woman was frustrated and confused by a dramatic increase in her electricity bills after her meter was changed in August 2013 – from $244 that July, to $403 in August, and up to $1,700 in January 2014.

An inmate had been waiting for months to have a wisdom tooth extracted and was in severe pain, to the point where he had fainted and had to be sent to hospital.

An inmate was told after a colonoscopy that he likely had bowel cancer and would need surgery immediately – within a week. However, the jail’s doctor told him the facility had no paperwork from the specialist, and it would be up to four weeks before he could even get an appointment for surgery.

After a woman was denied funding for a drug to treat neuropathic pain, her husband came to the Ombudsman for help. The woman has a rare neurological disease and her condition, which is considered palliative, means she has considerable muscle and nerve pain. One of the drugs that helped her pain, Sativex, was only approved for patients with multiple sclerosis, or palliative cancer patients with refractory pain.  

A 62-year-old woman with Crohn’s disease required infusions every eight weeks at a cost of $4,542.76 per treatment. The woman’s private insurance covered 80% of the costs, while the Trillium Drug Program reimbursed her for the remainder, but she was reaching the lifetime maximum for her private insurance coverage and it was about to end.